7 Article(s)Download |
||||||
PMID | Title | Pub. Year | #Total Relationships |
|||
1 | 21142269 | Effect of inhibition of cytochrome P450 enzymes 2D6 and 3A4 on the pharmacokinetics of intravenous oxycodone: a randomized, three-phase, crossover, placebo-controlled study. | 2011 | 1 | ||
2 | 20007670 | Identification of cytochrome P450 isoforms involved in the metabolism of paroxetine and estimation of their importance for human paroxetine metabolism using a population-based simulator. | 2010 Mar | 2 | ||
3 | 20642550 | Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone. | 2010 Jul | 1 | ||
4 | 18691982 | Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. | 2008 Jul | 1 | ||
5 | 12756206 | Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro. | 2003 Jun | 1 | ||
6 | 14703714 | Metabolic drug interactions with new psychotropic agents. | 2003 Oct | 1 | ||
7 | 11910269 | Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers. | 2002 Apr | 1 |